tbuckley/cabot-search huggingface dataset:
The buried stent: a rare complication of endoscopic ultrasound-guided pancreatic necrosectomy using a lumen-apposing metal stent
Authors: Ahmed Altonbary, Hazem Hakim
Journal: Endoscopy (2017)

A 51-year-old man was referred to our facility for endoscopic ultrasound-guided drainage of walled-off pancreatic necrosis. The cyst was first punctured with a 19-gauge needle ([Fig. 1]). A NAGI stent (Taewoong Medical, Seoul, South Korea) was then deployed under ultrasonographic and fluoroscopic guidance without difficulty ([Fig. 2], [Video 1]). A computed tomography (CT) scan 6 weeks later revealed significant reduction in the cyst size with residual necrotic debris. Upper endoscopy showed an orifice in the middle of a small bulge of gastric mucosa and the stent could not be seen. The cystogastrostomy tract was cannulated and dilated with a 15-mm pneumatic balloon ([Fig. 3]). The extremity of the lumen-apposing metal stent (LAMS) embedded in the gastric wall was identified, and the stent was removed using rat-tooth forceps ([Fig. 4]). The endoscope was then passed into the cyst cavity and the residual necrotic debris was irrigated and removed with a snare. A follow-up CT scan after 3 months revealed an almost totally collapsed cyst cavity, consistent with drainage of the collection.
Target-Mediated Drug Disposition of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma after Prior Proteasome Inhibitors and Immunomodulatory Drugs: A Population Pharmacokinetic Analysis
Authors: Xiaoyu Yan, Pamela L Clemens, Thomas Puchalski, Sagar Lonial, Henk M. Lokhorst, Robert Z. Orlowski, Nedjad Losic, Imran Khan, Richard Jansson, Tahamtan Ahmadi, Kristen Lantz, Juan Jose Perez Ruixo, Honghui Zhou, Xu Steven Xu
Journal: Blood (2015)
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)
Authors: Maria Q. Baggstrom, Mark A. Socinski, Xiaofei F. Wang, Lin Gu, Thomas E. Stinchcombe, Martin J. Edelman, Sherman Baker, Josephine Feliciano, Paul Novotny, Olwen Hahn, Jeffrey A. Crawford, Everett E. Vokes
Journal: Journal of Thoracic Oncology (2017)
Erratum to “Effect of DNA/liposome mixing ratio on the physicochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression”
Authors: Fuminori Sakurai, Rui Inoue, Yasunobu Nishino, Ayumu Okuda, Osamu Matsumoto, Tooru Taga, Fumiyoshi Yamashita, Yoshinobu Takakura, Mitsuru Hashida
Journal: Journal of Controlled Release (2000)
The Oral Iron Chelator Deferasirox for Treatment of Transfusional Iron Overload After Allogeneic Hematopoietic Cell Transplantation Does Not Appear to Interfere with the Calcineurin Inhibitor Cyclosporin Trough Serum Levels
Authors: Haifa Kathrin Al-Ali, Nadja Jaekel, Alexia Nass, Sandra Otto, Gesine Bug, Nicolaus Kroeger, Uwe Platzbecker, Michael Stadler, Katharina de Haas, Dietger W Niederwieser
Journal: Blood (2010)
Single Cell Phospho-Flow Analysis of Cytokine Stimulation in Human Hematopoietic Progenitors Reveals That G-CSF Acts Directly On Human Hematopoietic Stem Cells.
Authors: Kenneth Gibbs, Penney Gilbert, Irving L. Weissman, Helen M. Blau, Garry P. Nolan, Ravindra Majeti
Journal: Blood (2009)
NEW FINDINGS From the FRENCH COHORT of MYH9-RELATED DISORDERS: PHENOTYPE PECULIARITIES and GENOTYPE NOVELTIES on Behalf of the National French Reference Center on Inherited Platelet Disorders (CRPP)
Authors: Béatrice Saposnik, Sylvie Binard, Alan T. Nurden, Paquita Nurden, Nicole Schlegel
Journal: Blood (2011)
A Prognostic Index for Patients with Refractory or in First Relapsed Acute Myeloid Leukemia Treated with FLAG-Ida or Flago-Ida
Authors: Juan Miguel Bergua, Pau Montesinos, David Martinez-Cuadrón, Pascual Fernández-Abellán, Josefina Serrano, María José Sayas, Julio Prieto-Fernandez, Raimundo Garcia, Ana Julia Garcia-Huerta, Manuel Barrios, Cristina Pérez-López, Manuel Perez-Encinas, Adriana Siemele, Gabriela Rodriguez-Macias, Pilar Herrera-Puente, Rebeca Rodríguez-Veiga, Maria Pilar Martinez-Sanchez, Maria Lourdes Amador-Barciela, Miguel A. Sanz
Journal: Blood (2014)
Stereotactic radiation treatment planning with volumetric modulated arc therapy: Impact of duodenal sparing on pancreatic tumor coverage.
Authors: R. Kumar, J. Kang, J. M. Herman, R. Tuli, T. M. Pawlik, E. Tryggestad, K. Smith, T. L. DeWeese, J. Wong, E. C. Ford
Journal: Journal of Clinical Oncology (2011)

301 Background: Volumetric modulated arc therapy (VMAT) allows for intensity-modulated radiation delivery with faster treatment times and fewer delivered monitor units (MU). The dose-limiting structure for pancreatic stereotactic body radiation therapy (SBRT) is the duodenum. We evaluate VMAT dose distribution, delivery times, and the effect of duodenal sparing (DS) for pancreas SBRT. Methods: Plans of 15 patients with unresectable pancreatic cancer (14 head/1 tail) were selected. VMAT treatment planning with the “SmartArc” function of Pinnacle v. 8.9 was used to plan one fraction of 25 Gy to the PTV (gross tumor + 2 mm expansion) normalized to the 80% isodose line. Two VMAT SBRT plans were conducted for each case; the first did not attempt to spare the duodenum (non DS) while the second did (DS). Constraints were stomach/duodenum any point max &lt;30 Gy (for DS plan), liver D 50 &lt; 5 Gy, ipsilateral kidney D 25 &lt; 5 Gy, cord D max &lt; 5 Gy and stomach D 4 &lt; 22.5 Gy. Results: Gross tumor volume ranged from 58.4cm 3 to 320.3 cm 3 . The average overlap volume between PTV and the duodenum was 8.4 cm 3 . In 10/15 non-DS plans, the duodenal D max exceeded 30 Gy. With DS optimization, only 1/15 plans exceeded the 30 Gy threshold. These differences were statistically significant (p&lt;0.001). Typical MU and delivery times, as calculated by the planning software, were 5494 MU and 775 secs vs. 5296 MU and 703 secs for the DS and non-DS plans, respectively. The difference in delivery times was significant (p=0.01), but amounted to only 1.2 min on average. The average duodenal D max for non-DS plans was 30.4Gy, D 4% was 23.4 Gy. With DS, the average D max was reduced to 28.1Gy and D 4% to &lt;19.7 Gy (p&lt;0.001). As expected, VMAT plans with greater overlap between the duodenum and PTV had a higher duodenal D max . Conclusions: This study demonstrates the feasibility of VMAT for high-dose SBRT treatment of pancreatic cancer incorporating constraints to limit the dose to the duodenum. Future studies will evaluate whether VMAT with fractionated SBRT results in improved duodenal sparing more efficiently than traditional IMRT. No significant financial relationships to disclose.
Anti-Müllerian Hormone Trajectories Are Associated With Cardiovascular Disease in Women
Authors: Annelien C. de Kat, W. Monique Verschuren, Marinus J.C. Eijkemans, Frank J.M. Broekmans, Yvonne T. van der Schouw
Journal: Circulation (2017)

Background: Earlier age at menopause is widely considered to be associated with an increased risk of cardiovascular disease. However, the underlying mechanisms of this relationship remain undetermined. Indications suggest that anti-Müllerian hormone (AMH), an ovarian reserve marker, plays a physiological role outside of the reproductive system. Therefore, we investigated whether longitudinal AMH decline trajectories are associated with an increased risk of cardiovascular disease (CVD) occurrence. Methods: This study included 3108 female participants between 20 and 60 years of age at baseline of the population-based Doetinchem Cohort. Participants completed ≥1 of 5 consecutive quinquennial visits between 1987 and 2010, resulting in a total follow-up time of 20 years. AMH was measured in 8507 stored plasma samples. Information on total CVD, stroke, and coronary heart disease was obtained through a hospital discharge registry linkage. The association of AMH trajectories with CVD was quantified with joint modeling, with adjustment for age, smoking, oral contraceptive use, body mass index, menopausal status, postmenopausal hormone therapy use, diastolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, and glucose levels. Results: By the end of follow-up, 8.2% of the women had suffered from CVD, 4.9% had suffered from coronary heart disease, and 2.6% had experienced a stroke. After adjustment, each ng/mL lower log AMH level was associated with a 21% higher risk of CVD (hazard ratio, 1.21; 95% confidence interval, 1.07–1.36) and a 26% higher risk of coronary heart disease (hazard ratio, 1.25; 95% confidence interval, 1.08–1.46). Each additional ng/mL/year decrease of log AMH was associated with a significantly higher risk of CVD (hazard ratio, 1.46; 95% confidence interval, 1.14–1.87) and coronary heart disease (hazard ratio, 1.56; 95% confidence interval, 1.15–2.12). No association between AMH and stroke was found. Conclusions: These results indicate that AMH trajectories in women are independently associated with CVD risk. Therefore, we postulate that the decline of circulating AMH levels may be part of the pathophysiology of the increased cardiovascular risk of earlier menopause. Confirmation of this association and elucidation of its underlying mechanisms are needed to place these results in a clinical perspective.
Factors Predictive for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia in a Population-Based Provincial Transplant Cohort
Authors: Chinmay B. Dalal, Chandrakala Shanmukhaiah, Thomas J. Nevill, Michael J. Barnett, Stephen H. Nantel, Donna E. Hogge, Donna L. Forrest, Heather J. Sutherland, Kevin W. Song, Raewyn Broady, Maryse M. Power, Sujaatha Narayanan, Yasser R Abou Mourad, John D. Shepherd, Sean S Young, Tanya L. Gillan, Cynthia L. Toze
Journal: Blood (2012)
Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Blood Stem-Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma: Excellent Disease Control and Long-Term Survival Rates
Authors: Ryan D. Gentzler, Andrew M. Evens, Alfred W. Rademaker, Bharat B Mittal, Adam M. Petrich, Jessica K. Altman, Olga Frankfurt, Daina Variakojis, Seema Singhal, Jayesh Mehta, Joel R Green, Stephanie Williams, Lynne Kaminer, Leo I. Gordon, Jane N. Winter
Journal: Blood (2012)
T-Bird (thalidomide, clarithromycin/[Biaxin®], lenalidomide/[Revlimid®], Dexamethasone) Therapy for Upfront Use in Symptomatic Multiple Myeloma.
Authors: Tomer Mark, Morton Coleman, David S Jayabalan, Roger Pearse, Faiza Zafar, Scott Ely, Megan C. Manco, Mary Crann, John P. Leonard, Selina Chen-Kiang, Ruben Niesvizky
Journal: Blood (2009)
Dasatinib Once-Daily Dose Regimen Provides Robust Anti-Leukemic Activity While Avoiding Suppression of T Cell Activation.
Authors: Gary L Schieven, Rosemary Zhang, Sidney Pitt, Kelly McGlinchey, Krista Menard, Richard Smykla, Vojkan Susulic, Mei-Li Wen, Amy Wiebesiek, Robert Townsend, Francis Y. Lee
Journal: Blood (2009)
Novel wire-guided fine-gauge bougie dilator for transpapillary or endoscopic ultrasonography-guided biliary drainage
Authors: Hiroshi Kawakami, Yoshimasa Kubota
Journal: Endoscopy (2017)

Endoscopic management of biliary stricture generally requires dilation using devices such as an endoscopic retrograde cholangiopancreatography (ERCP) balloon dilation catheter before stenting [1]. Endoscopic ultrasonography (EUS)-guided biliary drainage (EUS-BD) also requires fistula dilation before stenting. Recently, ultraslim balloon catheters [1] and diathermic dilators [2] have also been developed as dilation devices. These devices must be wire-guided, coaxial with the guidewire, fine-gauge, and sufficiently stiff.
Integrating Molecular, Epigenetic and Pharmacogenetic Approaches in Managing Imatinib Resistance Among Malaysian Chronic Myeloid Leukemia Patients
Authors: Aziz Baba, Marjanu Hikmah Elias, Anthony Zian Au, Najlaa Maddin, Siti Maziras Makhtar, Gan Siew Hua, Azlan Husin, Sarina Sulong, Rosline Hassan, Ravindran Ankathil
Journal: Blood (2014)
Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting
Authors: Ali Akram, Derek Juang, Ranier Bustamante, Lin Liu, Ashley Earles, Samuel B. Ho, Jessica Wang-Rodriguez, James E. Allison, Samir Gupta
Journal: Clinical Gastroenterology and Hepatology (2017)
Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States
Authors: Bobby Daly, Olufunmilayo I. Olopade, Ningqi Hou, Katharine Yao, David J. Winchester, Dezheng Huo
Journal: JAMA Oncology (2017)

Randomized trials in breast cancer have demonstrated the clinical benefits of adjuvant endocrine therapy (AET) in preventing recurrence and death. The examination of concordance with AET guidelines at a national level as a measure of quality of care is important.To investigate temporal trends and factors related to receipt of AET for breast cancer.This retrospective cohort study included 981 729 women with breast cancer in the National Cancer Database from January 1, 2004, to December 31, 2013. Women with stages I to III breast cancer who received all or part of their treatment at the reporting institution were included in the analysis.Temporal changes in AET receipt (estimating the annual percentage change) and AET practice patterns (using logistic regression) and the effect of AET guideline concordance on survival of women with hormone receptor-positive (HR+) breast cancer (using the multivariable Cox proportional hazards model).Of the 981 729 eligible patients (mean [SD] age, 60.8 [13.3] years), 818 435 had HR+ and 163 294 had HR-negative (HR-) cancer. Among the patients with HR+ cancer, receipt of AET increased over time, from 69.8% in 2004 to 82.4% in 2013. Among patients with HR- cancer, receipt decreased from 5.2% in 2004 to 3.4% in 2013. Hospital-level adherence (≥80% of patients with HR+ cancer received AET) increased from 40.2% in 2004 to 69.2% in 2013. Receipt of AET varied significantly by age (lower in patients ≥80 years), race (lower in African American and Hispanic participants), geographic location (lower in West South Central, Mountain, and Pacific census regions), and receptor status (lower in patients with estrogen receptor-negative and progesterone receptor-positive cancer). Surgery and radiotherapy were the factors most significantly associated with appropriate AET receipt (only 45.0% in patients who received lumpectomy without radiotherapy). Receipt of AET was associated with a 29% relative risk reduction in mortality. Based on this effectiveness estimate, if all patients with HR+ cancer received AET, approximately 14 630 lives would have been saved over 10 years.From 2004 to 2013, underuse and misuse of AET have decreased for patients with breast cancer, but optimal use has not been achieved, and significant variation in care remains. The involvement of surgery and radiotherapy were among the most significant factors associated with optimal use, which underscores the benefits of team-based care to support guideline-concordant therapy.
Use of contrast-enhanced ultrasound imaging with microbubbles targeted to α<sub>v</sub>β<sub>3</sub> integrins to enhance detection of early-stage ovarian tumors.
Authors: A. Barua, A. Yellapa, P. Bitterman, J. M. Bahr, S. Sharma, D. B. Hales, J. L. Luborsky, J. S. Abramowicz
Journal: Journal of Clinical Oncology (2011)

5076 Background: Lack of an early detection test makes ovarian cancer (OVCA) a lethal gynecological malignancy. Tumor associated neo-angiogenesis (TAN) is an early event in tumor development and represents a potential target for early detection. Traditional transvaginal ultrasound (TVUS) cannot detect TAN at early stage. The goal of this pilot study was to examine the enhancement of TVUS using αvβ3 integrins targeted microbubble ultrasound contrast agent (UCA) in laying hens, a preclinical spontaneous model of human OVCA. Methods: 3-4 years old hens (n=50) were selected randomly and scanned continuously by TVUS before, during and after UCA (Visister-integrins, Targeson Inc. CA) injection at brachial veins. UCA was visualized using a low mechanical index contrast imaging pulse sequence. All pre- and post-contrast injection images were archived and analyzed off-line. Gross diagnosis was recorded at euthanasia and tissues were processed for histology. Tumors and their types were confirmed by routine histology. TAN markers (SMA and αvβ3 integrins) were detected by immunohistochemistry. TAN vessels were counted and correlation with ultrasound prediction was examined. Results: αvβ3-integrins targeted UCA enhanced the visualization of ovarian tumors significantly in laying hens. At gray scale, UCA bounded areas appeared as a ring on the ovarian surfaces of 8 of 50 hens and were suspected for ovarian tumors. Tumors were confirmed in all hens predicted to have OVCA. In 7 hens tumors were early stage and in one hen the tumor metastasized to the oviduct. A microscopic lesion was found in one hen which was not detected by ultrasound imaging. Thus 9 of 50 hens had ovarian tumors and UCA detected approximately 88% at early stages. The frequency of immunopositive TAN vessels (SMA and αvβ3 integrins positive) were significantly higher in OVCA hens than normal hens (P<0.05) and was positively correlated (0.86, P< 0.05) with ultrasound prediction. Conclusions: Our results demonstrate that UCA targeting αvβ3 integrin enhanced TVUS detection of early stage ovarian tumors in a pre-clinical model and may form the foundation for a clinical study. Support: Department of Defense (#09-3303), Sramek Foundation.
Platelets Protect From Lipopolysaccharide-Induced Lethal Endotoxemia by Inhibiting Macrophage-Dependent Inflammation Via the Cyclooxygenase 1 (COX1) Signaling Pathway
Authors: Binggang Xiang, Guoying Zhang, Xiang-An Li, Andrew J. Morris, Alan Daugherty, Sidney W. Whiteheart, Susan S. Smyth, Zhenyu Li
Journal: Blood (2012)
Ex Vivo Expansion of Cord Blood Natural Killer Cells Overcomes Impaired Immune Synapse Formation and Effector Function in Acute Myeloid Leukemia
Authors: Dongxia Xing, Alan G Ramsay, John G. Gribben, William K Decker, Jared K Burt, Sufang Li, Simon N Simon, Hong Yang, Laurence Cooper, John D. McMannis, Richard E Champlin, Elizabeth J Shpall, Patrick Zweidler-McKay, Catherine M. Bollard
Journal: Blood (2008)
Incidence of syn- and metachronous adrenal metastasis following tumor nephrectomy: A retrospective bicenter analysis.
Authors: Inga Peters, Thomas R. W. Herrmann, Christoph von Klot, Gerd Wegener, Petr Stransky, Ondrej Hes, Milan Hora, Markus Kuczyk, Axel S. Merseburger
Journal: Journal of Clinical Oncology (2012)

417 Background: Metastases of adrenal gland occur in approximately 1.2 - 10% in kidney cancer patients. Synchronous adrenalectomy has become dispensable since studies have demonstrated no clinical benefit. The aim of this large bi-institutional study was to determine the appearance of syn- and metachronous metastasis to the adrenal gland as detected by CT, PET-CT or MRI imaging with consecutively surgically removal of suspicious lesions. Methods: We retrospectively reviewed the clinical and pathological records of 2308 patients (1200 pts. from Medical School Hanover until 2009 and 1108 pts. from University Hospital Plzeň until 2010) who underwent radical/partial nephrectomy. Synchronous adrenalectomy was carried out in 222 of all cases (10.4%). Metachronous adrenalectomy was performed in 11 cases including 8 ipsilateral and 3 contralateral adrenalectomies due to suspicious imaging among follow-up. In cases of metachronous metastasis pre-operative imaging, surgical and histopathological results were correlated. Results: Metastatic spread in patients with synchronous adrenalectomy was found in 17/222 cases (7.6%), as suspected. In metachronous procedures positive pathological results was found in 10 of 11 (91%) cases. In one case it was a benign pathological result. In all positive cases a metastasis from the former clear cell carcinoma was pathologically confirmed. 27% of all cases were detected in the contralateral adrenal gland. Conclusions: Synchronous adrenalectomy is not routinely recommended with nephrectomy. In case of preoperative suspicious imaging an intraoperative frozen section should be performed. Radiological investigations are of high diagnostic value for detecting metachronous tumor growth within the adrenal gland. Surgery in this scenario should be recommended due to the here reported malignancy rate of 91%.
Redox Proteins GSTs A1, M1, O1, O2, P1; Prx-3, and Trx-1 Association with In Vitro Imexon Sensitivity in Multiple Myeloma Cell Lines.
Authors: Michael A. Thompson, Lan V. Pham, Linda Yoshimura, Amanda F. Baker, Evan M. Hersh, Robert T. Dorr, Richard J. Ford
Journal: Blood (2006)
NIMG-48MR DIFFUSION PROFILES OF NON-ENHANCING LOWER-GRADE GLIOMAS
Authors: Tracy Luks, Tracy Richmond McKnight, Aurelia Williams, Khadjia Lobo, Anders Persson, Joanna Phillips, Annette Molinaro, Susan Chang, Sarah Nelson
Journal: Neuro-Oncology (2015)

MR diffusion profiles of 134 non-enhancing grade 2 and grade 3 gliomas were examined by histologic and molecular characteristics. These diffusion parameters reflect characteristics of tumor microstructure, and may be predictive of tumor aggressiveness or therapeutic response. Patients with suspected glioma underwent a pre-surgical 3T MR exam, with T1, T2, and diffusion sequences. Histological sub-type (AS, OA, or OD), grade, IDH, 1p19q, and p53 status were determined by standard pathology and immunohistochemistry assessment of tumor tissue samples. Median, 10th percentile, and 90th percentile of Apparent Diffusion Coefficient (ADC) and eigenvalues (EVaxial, EVradial) for the T2 abnormality region were calculated, both as absolute and relative values scaled by intensities from normal appearing white matter. Smaller tumor volume was associated with lower ADC and EV parameters (median ADC and EVradial, 90% nEVaxial, EVaxial, and ADC, and 10% EVaxial, nEVaxial and EVradial). Tumor grade was associated with 90% ADC, EVaxial, and nEVaxial values, with lower values for grade 3 than grade 2 tumors. Tumor histology sub-type was associated with 90% nEVaxial, with lower values in OD than OA or AS. IDH+ status was associated with higher values of median EVaxial, and 10% of nEVaxial, nEVradial, and EVradial. 1p19q deleted status was associated with lower values of median nEVaxial and EVradial, 10% EVaxial, nEVaxial and EVradial. P53+ status was associated with higher EV values, but these were not significant when controlling for tumor histology sub-type. No MR diffusion parameters were associated with progression-free survival (PFS), but the PFS was significantly longer in IDH+ compared to IDH- patients, and longer for patients with lesions that were 1p19q deleted, compared with 1p19q non-deleted or aneuploidy in nature. MR diffusion parameters may therefore be of value for non-invasive assessment and treatment planning of non-enhancing glioma and contribute to our understanding of variations in tumor microstructure.
Prospective Evaluation of An Argatroban Dosing Nomogram Using the Ecarin Chromogenic Assay at a Tertiary Institution
Authors: Cathryn Sibbald, Jin-Hyeun Huh, William Brien, Bassem Hamandi, Donna Lowe, Menaka Pai, Anne Mcleod, Gary Wong, Erik Yeo, David Barth
Journal: Blood (2008)
Improved Survival in Red Blood Cell Transfusion Dependent Patients with Primary Myelofibrosis (PMF) Receiving Iron Chelation Therapy.
Authors: Heather Leitch, Hatoon Ezzat, Meaghan D Rollins, Trisha A Goodman, Chantal S Leger, Dominic HC Wong, Khaled M Ramadan, Lynda M Foltz, Linda M Vickars
Journal: Blood (2008)
Multiple Myeloma: Global Expression Profiling (GEP) Indicates Upregulation of the Ribosomal Machinery in Hyperdiploid Clones.
Authors: Friedrich W. Cremer, John De Vos, Dirk Hose, Jean François Rossi, Carina Ittrich, Thierry Rème, Axel Benner, Eric Jourdan, Marc S. Raab, Jelena Bila, Ann-Cathrin Theil, Sunitha Jonnakuty, Coral del Val, Marion Moos, Hartmut Goldschmidt, Bernard Klein, Anna Jauch
Journal: Blood (2004)